GL1X · GenesisL1 explorer

Research workbench

HSP90 alpha N-terminal domain in complex with a macrocyclic inhibitor, CH5164840

Analyse HSP90 alpha N-terminal domain in complex with a macrocyclic inhibitor, CH5164840 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3VHD
Type
protein
Length
428 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Heat shock protein HSP 90-alpha
UniProt
P07900
Ligands
VHE
Pockets
2 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 39% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHeat shock protein HSP 90-alphaprotein21338% helix, 23% strandP07900
BHeat shock protein HSP 90-alphaprotein21539% helix, 22% strandP07900

Ligands and binding sites

  • VHE · 4-amino-18,20-dimethyl-7-thia-3,5,11,15-tetraazatricyclo[15.3.1.1(2,6)]docosa-1(20),2,4,6(22),17(21),18-hexaene-10,16-dione · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17660.750.8068VHE
23190.650.8031VHE

Interfaces

1 interface between chains.

  • A–B · 404 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 3VHD · Hsp90 alpha N-terminal domain in complex with a macrocyclic inhibitor, CH5164840 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.